No phaseSuspended

Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy 3 (LOPAIN3)

Clinical Investigation Plan First in Human Trial Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy "LOPAIN3"

Sponsor
Spinal Stabilization Technologies (Industry)
Enrollment
50 planned
Conditions
Back Pain With Radiation; Radiculopathy; Back Pain; Disc Herniation; Herniated Nucleus Pulposus; Herniated Disc; Disc Injury; Disk Herniated Lumbar
Interventions
PerQdisc Nucleus Replacement System
Ages
adults, older adults
Registry
NCT05732818

Full record on ClinicalTrials.gov

From the registry

This study is a First in Human, prospective, multi-center clinical study intended to collect safety and performance information for the Spinal Stabilization Technologies PerQdisc® Nucleus Replacement System and procedure concurrently following a successful discectomy using a minimally invasive posterolateral (MIPL) approach. Patients that are at least 21 years or older, presenting with symptomatic radiculopathy from a focal lumbar disc herniation that requires surgical decompression will be included in this study.

Primary outcomes

  • Safety: Number of Patients with Serious Adverse Events related to the PerQdisc

History

  1. Study completion expected

  2. Primary completion expected

  3. Last registry update

  4. Started

  5. Registered